621
Participants
Start Date
February 29, 2008
Primary Completion Date
May 31, 2011
Study Completion Date
August 31, 2011
BIIB019 (Daclizumab High Yield Process)
SC injection
Placebo
Placebo SC injection
Research Site, Brno
Research Site, Olomouc
Research Site, Pilsen
Research Site, Teplice
Research Site, Erlangen
Research Site, Marburg
Research Site, Osnabrück
Research Site, Regensburg
Research Site, Rostock
Research Site, Budapest
Research Site, Debrecen
Research Site, Esztergom
Research Site, Győr
Research Site, Kecskemét
Research Site, Miskolc
Research Site, Nyíregyháza
Research Site, Siófok
Research Site, Zalaegerszeg
Research Site, Andra-Pradeash
Research Site, Bangalore
Research Site, Chennai
Research Site, Kolkata
Research Site, Mumbai
Research Site, Rajasthan
Research Site, Visakhapatnam
Research Site, Bialystok
Research Site, Gdansk
Research Site, Katowice
Research Site, Krakow
Research Site, Lodz
Research Site, Lublin
Research Site, Warsaw
Research Site, Kazan'
Research Site, Krasnoyarsk
Research Site, Moscow
Research Site, Nizhny Novgorod
Research Site, Novosibirsk
Research Site, Omsk
Research Site, Saint Petersburg
Research Site, Samara
Research Site, Smolensk
Research Site, Ufa
Research Site, Yaroslavl
Research Site, Chernivtsi
Research Site, Dnipropetrovsk
Research Site, Donetsk
Research Site, Kharkiv
Research Site, Kiev
Research Site, Lviv
Research Site, Poltava
Research Site, Zaporizhzhya
Research Site, London
Research Site, Nottingham
Research Site, Plymouth
Research Site, Sheffield
Research Site, Stoke-on-Trent